Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

August 25, 2017August 31, 2017

Androgen Deprivation Therapy May Increase Risk for Heart Failure, Study Says

News

Men with localized prostate cancer who received androgen deprivation therapy may be at greater risk of heart failure than those who did not receive the treatment, a new study suggests. ... Read more

August 24, 2017August 24, 2017

AIM1 Protein Decreases the Potential for Metastasis by Prostate Cancer Cells, Study Shows

News

Scientists at the Johns Hopkins Kimmel Cancer Center discovered that a protein called AIM1 keeps prostate cancer cells from acquiring properties that allow them to invade and spread within the body. Cells ... Read more

August 21, 2017August 21, 2017

Prostate Cancer Patients Usually Report Their Comorbidities Accurately, Prospective Study Shows

News

Prostate cancer patient reports are a reliable strategy for assessing the presence of certain comorbidities, according to a study by the University of North Carolina (UNC). The study, “Comparison of Patient Report ... Read more

July 21, 2017July 21, 2017

Active Surveillance May Increase Likelihood of Adverse Outcomes in Low-Volume Intermediate-Risk Prostate Cancer

News

Active surveillance may expose men with intermediate-risk prostate cancer to adverse outcomes that could be avoided by immediate intervention, according to the findings of a large cohort study. The study, ... Read more

July 20, 2017

A Vasectomy Does Not Increase Risk of Prostate Cancer, Mayo Clinic Study Reports

News

No association between vasectomy and any form of prostate cancer showed up in a review of research and an analysis of factors across studies, Mayo Clinic researchers reported. This means ... Read more

July 18, 2017July 18, 2017

Prostate Surgery May Not Decrease Death Toll in Low-Risk Prostate Cancer Patients, Long-term Study Finds

News

In a follow-up study spanning almost 20 years, researchers found that surgery does not decrease mortality outcomes in patients with localized prostate cancer. In fact, the results showed that surgery ... Read more

May 16, 2017

Provenge Immunotherapy Increases Overall Survival in African-American Men with Metastatic Prostate Cancer

News

African-American men with metastatic castrate-resistant prostate cancer survive significantly longer than Caucasian men when treated with Provenge, according to new findings from Dendreon’s PROCEED registry, which is following patients’ outcomes in a ... Read more

May 2, 2017

Gene Editing Improves Prostate Cancer Survival, Study in Mice Shows

News

A new therapy targeting genomic rearrangements, such as fused genes that promote tumor development, significantly improved survival in mice with aggressive forms of prostate and liver cancer. The study, “Targeting ... Read more

May 1, 2017May 1, 2017

Prostate Cancer’s Aggressive Nature in Black Americans Suggests Need for More Personalized Screening

News

The higher rates at which black men are dying of prostate cancer may be linked to faster disease progression, according to a new study. The results suggest that African-Americans should ... Read more

April 18, 2017

CTT to Present Data on Prostate Cancer Therapy Candidates at Upcoming Conferences

News

The most recent performance data on Cancer Targeted Technology’s (CTT) leading drugs, CTT1057 and CTT1403, in prostate cancer clinical and preclinical studies will be presented at several scientific and business ... Read more